Literature DB >> 18342077

[Sporotrichoid cutaneous leishmaniasis in Tunisia: a clinical and histological study].

A Masmoudi1, N Ayadi, A Khabir, L Bouzid, S Bouassida, T J Meziou, F Akrout, A Zahaf, T Boudawara, H Turki.   

Abstract

BACKGROUND: The sporotrichoid variety of cutaneous leishmaniasis is defined by the presence of dermal and hypodermal nodules along the lymphatic stream, and remote from the primary inoculation lesions. This clinical form is usually considered rare. The aim of our study was to investigate the epidemiological, clinical, histological and evolutionary particularities of sporotrichoid cutaneous leishmaniasis in the south of Tunisia. PATIENTS AND METHODS: During a systematic study of all cases of cutaneous leishmaniasis from the south of Tunisia diagnosed in our hospital in 2002, sporotrichoid forms were diagnosed on the basis of clinical criteria. In all cases of sporotrichoid cutaneous leishmaniasis, the principal clinical characters were systematically specified. Cutaneous biopsies of subcutaneous nodules were performed in six cases.
RESULTS: Of 102 patients with cutaneous leishmaniasis, 19 presented sporotrichoid cutaneous leishmaniasis, that is, a frequency of 19%. Between two and 20 painless subcutaneous nodules were arranged in linear strings on the upper leg in 79% of cases. Time to appearance varied between 12 days and one year after the primary lesions. Fourteen appeared without any preliminary treatment for cutaneous leishmaniasis and five appeared after Glucantime infiltration in the primary lesions. Biopsies of the nodules showed an inflammatory infiltrate composed of lymphocytes and histiocytes. This infiltrate was particularly dense and rich in plasmocytes at the level of the deep dermis. The biopsies were deep enough to involve the hypoderm in one case and the same type of infiltrate was noted at the level of interlobular septa. A small number amastigotes was seen in one deep biopsy sample. Outcome was favourable in all cases under treatment.
CONCLUSION: Sporotrichoid cutaneous leishmaniasis appears to be common in the south of Tunisia, were cutaneous leishmaniasis is dominant because of Leishmania major. It is not associated with a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342077     DOI: 10.1016/j.annder.2007.04.005

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  5 in total

1.  Old World cutaneous leishmaniasis: diagnosis and treatment.

Authors:  Abderrahmen Masmoudi; Wala Hariz; Slaheddine Marrekchi; Mariem Amouri; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2013-06-30

2.  Lymphatic Dissemination in Cutaneous Leishmaniasis Following Local Treatment.

Authors:  Elena Thomaidou; Liran Horev; Deborah Jotkowitz; Mariana Zamir; Arieh Ingber; Claes D Enk; Vered Molho-Pessach
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

3.  Clinical Features of Anthroponotic Cutaneous Leishmaniasis in a Major Focus, Southeastern Iran, 1994-2014.

Authors:  Ahmad Khosravi; Iraj Sharifi; Alireza Fekri; Alireza Kermanizadeh; Mehdi Bamorovat; Mahshid Mostafavi; Mohammad Reza Aflatoonian; Alireza Keyhani
Journal:  Iran J Parasitol       Date:  2017 Oct-Dec       Impact factor: 1.012

4.  Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil.

Authors:  Livia Martins Veloso de Carvalho; Maria Inês Fernandes Pimentel; Fátima Conceição-Silva; Érica de Camargo Ferreira E Vasconcellos; Cláudia Maria Valete-Rosalino; Marcelo Rosandiski Lyra; Mariza de Matos Salgueiro; Maurício Naoto Saheki; Maria de Fátima Madeira; Eliame Mouta-Confort; Liliane de Fátima Antonio; Aline Fagundes da Silva; Leonardo Pereira Quintella; Sandro Javier Bedoya-Pacheco; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-06-01       Impact factor: 1.846

5.  Evaluation of leishmanin skin test reaction in different variants of cutaneous leishmaniasis.

Authors:  Giti Sadeghian; Hengameh Ziaei; Leila Shirani Bidabadi; Mohammad Ali Nilforoushzadeh
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.